+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Respiratory Drugs Market Research Reports

Bacterial Pneumonia - Pipeline Insight, 2024 - Product Thumbnail Image

Bacterial Pneumonia - Pipeline Insight, 2024

  • Clinical Trials
  • April 2024
  • 60 Pages
  • Global
From
Bronchitis - Pipeline Insight, 2024 - Product Thumbnail Image

Bronchitis - Pipeline Insight, 2024

  • Clinical Trials
  • April 2024
  • 50 Pages
  • Global
Community-acquired pneumonia (CAP) - Pipeline Insight, 2024 - Product Thumbnail Image

Community-acquired pneumonia (CAP) - Pipeline Insight, 2024

  • Clinical Trials
  • April 2024
  • 60 Pages
  • Global
From
Sleep apnoea syndrome - Pipeline Insight, 2024 - Product Thumbnail Image

Sleep apnoea syndrome - Pipeline Insight, 2024

  • Clinical Trials
  • April 2024
  • 50 Pages
  • Global
From
Neonatal respiratory distress syndrome - Pipeline Insight, 2024 - Product Thumbnail Image

Neonatal respiratory distress syndrome - Pipeline Insight, 2024

  • Drug Pipelines
  • April 2024
  • 60 Pages
  • Global
From
Pulmonary alveolar proteinosis - Pipeline Insight, 2024 - Product Thumbnail Image

Pulmonary alveolar proteinosis - Pipeline Insight, 2024

  • Clinical Trials
  • April 2024
  • 40 Pages
  • Global
From
From
Budesonide Market Size, Forecast, and Drug Insight - 2032 - Product Thumbnail Image

Budesonide Market Size, Forecast, and Drug Insight - 2032

  • Report
  • February 2024
  • 30 Pages
  • Global
Alpha-1 Antitrypsin Deficiency - Epidemiology Forecast - 2032 - Product Thumbnail Image

Alpha-1 Antitrypsin Deficiency - Epidemiology Forecast - 2032

  • Report
  • January 2024
  • 106 Pages
  • Global
From
From
From
IgE receptor antagonists - Pipeline Insight, 2024 - Product Thumbnail Image

IgE receptor antagonists - Pipeline Insight, 2024

  • Drug Pipelines
  • January 2024
  • 60 Pages
  • Global
From
Integrin alpha4beta1 antagonists - Pipeline Insight, 2024 - Product Thumbnail Image

Integrin alpha4beta1 antagonists - Pipeline Insight, 2024

  • Drug Pipelines
  • January 2024
  • 60 Pages
  • Global
From
Leukotriene Antagonist - Pipeline Insight, 2024 - Product Thumbnail Image

Leukotriene Antagonist - Pipeline Insight, 2024

  • Clinical Trials
  • January 2024
  • 60 Pages
  • Global
From
Leukotriene D4 Antagonist - Pipeline Insight, 2024 - Product Thumbnail Image

Leukotriene D4 Antagonist - Pipeline Insight, 2024

  • Clinical Trials
  • January 2024
  • 60 Pages
  • Global
From
From
From
Epithelial Sodium Channel (ENaC) Inhibitor - Pipeline Insight, 2024 - Product Thumbnail Image

Epithelial Sodium Channel (ENaC) Inhibitor - Pipeline Insight, 2024

  • Clinical Trials
  • January 2024
  • 60 Pages
  • Global
From
From
From
Loading Indicator

The Respiratory Drugs market is a sector of the pharmaceutical industry that focuses on the development and production of drugs used to treat respiratory diseases. These drugs are used to treat a variety of conditions, including asthma, chronic obstructive pulmonary disease (COPD), and cystic fibrosis. Commonly prescribed respiratory drugs include bronchodilators, corticosteroids, and antibiotics. The Respiratory Drugs market is highly competitive, with many large pharmaceutical companies vying for market share. Companies in the market include GlaxoSmithKline, AstraZeneca, Merck & Co., Novartis, and Boehringer Ingelheim. These companies are constantly researching and developing new drugs to treat respiratory diseases, as well as improving existing treatments. Show Less Read more